Table 2

VE concentration, ROS activity, SOD activity, GSH activity and MDA content in mice serum from different groups (mean ± sd, n = 12)

Group

Vitamin E

(μg/ml)

ROS

(U/ml)

SOD

(U/ml)

MDA

(mmol/ml)

GSH-Px

(U/ml)

Control

6.05 ± 1.81

1002.66 ± 112.72

164.79 ± 32.49

9.84 ± 1.16

746.03 ± 10.19

C+VE

14.23 ± 2.88^b

511.23 ± 85.45

200.87 ± 30.22

9.22 ± 1.24

800.94 ± 12.55

C+Q

5.01 ± 0.82

811.04 ± 43.54

152.27 ± 26.45

10.28 ± 1.12

752.16 ± 11.68

TS

3.82 ± 2.55^a

1238.71 ± 33.63^c

131.93 ± 29.49^e

10.54 ± 1.20

679.66 ± 6.25^f

TS+Q

7.11 ± 1.74

1155.87 ± 111.85^d

157.11 ± 16.96

9.95 ± 1.59

689.33 ± 4.32^f

TS+ VE

12.08 ± 0.88^b

577.88 ± 92.47

213.01 ± 25.35

9.97 ± 1.13

677.36 ± 4.50^f

TS+VE+Q

12.02 ± 1.33^b

748.43 ± 43.36

226.05 ± 33.14

9.76 ± 0.96

667.56 ± 8.10

^aVE was significant lower than that in other groups (p < 0.05); ^b VE in VE treated groups was significantly higher than those in other control groups (p < 0.05). ^cROS activity was significantly higher than that in control groups and VE treated groups; ^dROS activity was significantly higher than that in C+Q, C+VE, TS+VE and TS+VE+Q groups. ^eThe level of SOD activity was significantly lower than that in VE treated groups. No statistical significance was observed on MDA content in different groups.^fGSH-Px activities were significantly lower than those in control groups.

Yang et al. BMC Cancer 2008 8:383   doi:10.1186/1471-2407-8-383